Professor Alice Egerton completed her undergraduate degree in pharmacology at the University of Glasgow and PhD at the University of Strathclyde before moving to Imperial College London. She joined the Department of Psychosis Studies at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London in 2008.
Her research applies human brain imaging and complementary techniques to study the neurobiology of schizophrenia. She is interested in why schizophrenia develops, why symptoms and responses to medication vary between individuals, and in developing novel treatments through experimental medicine studies and clinical trials. Techniques include magnetic resonance spectroscopy (MRS, especially to study brain glutamate), PET, fMRI and structural MRI. She is also the Deputy Lead for the Experimental Medicine and Novel Therapeutics Theme of the NIHR-Maudsley Biomedical Research Centre for Mental Health and Programme Leader for the MSc in Psychiatric Research at the IoPPN.